Anzeige
Mehr »
Mittwoch, 22.04.2026 - Börsentäglich über 12.000 News
BREAKING: Pacifica liefert hochgradige Treffer - Phase II trifft genau ins Ziel
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DiElastic launches MCP Apps for security and observability workflows
DiStifel raises MaxLinear stock price target on infrastructure growth
DiNeedham raises Vicor stock price target to $260 on strong outlook
DiRaymond James upgrade Ball, downgrades Graphic Packaging
DiBofA cuts PPL stock price target to $42 on Q1 earnings view
DiBofA raises target for eBay, Carvana as e-commerce rebounds despite macro concerns
DiFreedom Broker raises PrimeEnergy stock price target on gas shift
DiKalshi reportedly launching crypto perpetual futures in coming weeks
DiMeta to track employee keystrokes to train AI models, Reuters reports
DiFDA approves Merck's Idvynso for HIV-1 treatment switch
DiTravel sector shows mixed outlook ahead of 2026 earnings season, Jefferies says
DiMorgan Stanley reiterates Eli Lilly stock rating on Medicare coverage outlook
DiPratt & Whitney invests $100M to expand US engine maintenance facilities
DiPratt & Whitney invests over $100M in U.S. engine maintenance sites
DiAdtran partners with GLDS for automated Wi-Fi management system
DiPlusAI terminates SPAC merger with Churchill Capital IX
DiMicrosoft faces UK lawsuit over cloud computing licence pricing
DiValero downgraded despite strong earnings outlook as valuation concerns mount
DiIndependent Bank declares $0.28 quarterly dividend
DiOmnicom partners with Adobe on AI marketing solution
DiRaymond James raises MSCI stock price target on sales momentum
DiMuted Growth, Rising AI Disruption: IT Services Sector Faces Uncertain 2026
DiJefferies cuts Tractor Supply stock price target on comp outlook
DiStifel reiterates Summit Therapeutics stock rating on trial data
DiCorcept to present ovarian cancer trial data at ASCO meeting